Hess G, Dreyling M, Oberic L, Gine E, et al. Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review study. Br J Haematol 2022 Oct 18. doi: 10.1111/bjh.18519.
PMID: 36257914